Analysis of postoperative purulent-septic complications in women with purulent-inflammatory diseases of the pelvic organs in terms of emergency gynecological care

July 24, 2020
565
Resume

The aim of the study was to analyze postoperative purulent-septic complications in women with purulent-inflammatory diseases of the pelvic organs in the conditions of urgent gynecological care. Object and research methods. The analysis of cases of postoperative purulent-septic complications in 52 patients who underwent urgent surgical treatment for purulent-inflammatory diseases of the pelvic organs was performed. Results. The average age of patients was 36.7±1.4 years. Postoperative purulent-septic complications were observed in 36.5% and most often occurred in patients undergoing treatment for pelvic abscess and septic community-acquired abortion. The occurrence of purulent-septic complications in these women was 100% (relative risk (RR) 2.2; p=0.03). A relationship was found between the severity of the patient’s condition and the frequency of development of postoperative purulent-septic complications. So, in patients undergoing community-acquired septic abortion, the average number of leukocytes was 22.0±3.0 • 109/l (RR 3.3; p<0.05). Of the 19 patients who had postoperative purulent-septic complications, 14 (73.7%) had a history of artificial abortion (RR 1.36). According to the results of intraoperative bacteriological research, it turned out that the bacterial flora was detected in only 59.6%, and was mainly represented by Staphylococcus and Esсherichia coli. Findings. The percentage of postoperative purulent-septic complications among patients with purulent-inflammatory diseases of the pelvic organs was 36.5%. The frequency of purulent-septic complications depends on the severity of the patient’s condition and signs of general intoxication. The presence in a woman’s history of artificial abortions increases the risks of a purulent-inflammatory process. The study of the occurrence of postoperative purulent-septic complications requires further analysis on an extended sample.

Published: 24.07.2020

References:

  • Ziganshin A.M., Mudrov V.A. (2019) Optimizatsiya kompleksnoy terapii vospalitelnyih zabolevaniy organov malogo taza u zhenschin. Ginekologiya, 21(3): 30–34.
  • Kudekenova S.B., Mustafina A.A., Alekseeva T.A., Mustafina G.G. (2015) Patogeneticheskie osobennosti profilaktiki gnoyno-septicheskih oslozhneniy v akusherstve i ginekologii. Vest. Novgor. gos. un-ta, 2(85): 130–132.
  • Kuzin M.I., Vetshev P.S., Kuzin N.M. (2006) Hirurgicheskie bolezni. Moskva, 784.
  • Nikitin D.A. (2003) Vozmozhnosti prognozirovaniya i profilaktiki gnoyno- vospalitelnyih oslozhneniy v sovremennoy operativnoy ginekologii. Belorus. med. zhurn., 4: 81–84.
  • Rozhkovska N.M., Sytnik P.O. (2016) Prohnozuvannia ryzyku uskladnen zapalnykh protsesiv orhaniv maloho taza u zhinok. Bukovyn. med. visn., 20(3): 147–150.
  • Shlyapnikov M.E., Kuznetsova L.V., Tarasova A.V. (2018) Effektivnost primeneniya deeskalatsionnoy stupenchatoy kombinirovannoy antibakterialnoy terapii v kompleksnom lechenii patsientok s tyazhelyimi infektsionno-vospalitelnyimi zabolevaniyami matki i ee pridatkov. Vest. med. in-ta «REAVIZ», 2: 82–86.
  • Brady P.C. (2016) Pelvic inflammatory disease and tubo-ovarian abscesses. Handbook of consult and inpatient gynecology, 121–133 р. DOI:10.1007/978-3-319-27724-06.
  • Brunham R.C., Gottlieb S.L., Paavonen J. (2015) Pelvic inflammatory disease. N. Engl. J., 372(21): 2039–2048. DOI:10.1056/NEJMra1411426.
  • Shinkov A.S., Sekretareva N.V., Stulova S.V., Ivantseva N.V. (2017) Pelvic inflammatory diseases with space occupying process in the uterine appendages among women in anemergency hospital. Совр. тенд. разв. наук. технол., 3–2: 6–8.
  • Tymon-Rosario J. (2019) Streptococcus constellatus Peritonitisand Subsequent Septic Shock following Intrauterine Device Removal Case Reports in Obstetrics and Gynecology, 2019: 5 p. DOI: 10.1155/2019/6491617.
  • Zaporozhan V., Marichereda V., Sytnik P. (2019) Inflammation biomarkers in pelvic inflammatory disease. Eur. J. Obstetr. Gynecol. Reproduct. Biol., 234: e43. DOI: 10.1016/j.ejogrb.2018.08.249.